QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
LON:TRLS

Trellus Health (TRLS) Share Price, News & Analysis

GBX 3.75
0.00 (0.00%)
(As of 02/23/2024 ET)
Today's Range
3.55
3.75
50-Day Range
3.10
5.50
52-Week Range
2.94
9.65
Volume
181 shs
Average Volume
141,482 shs
Market Capitalization
£6.06 million
P/E Ratio
355.00
Dividend Yield
N/A
Price Target
N/A

About Trellus Health

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.

TRLS Stock Price History

TRLS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive TRLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trellus Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
31
Year Founded
N/A

Profitability

Net Income
£-7,540,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£35,000.00
Cash Flow
GBX 4.95 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£6.06 million
Optionable
Not Optionable
Beta
0.23
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Marla Cindy Dubinsky M.D.
    Co-Founder, CEO & Director
  • Dr. Laurie Keefer Ph.D.
    Co-Founder & Chair of Scientific Advisory Board
  • Ms. Joy Bessenger B.A.
    Chief Financial Officer
  • Aled Stevenson
    Chief Operating Officer
  • Jamey Hancock
    Chief Technology Officer
  • Amy Murphy
    Director of Human Resources
  • Dr. Andres Jimenez M.B.A.
    M.D., M.S., Chief Medical Information Officer
  • Leah Conley M.B.A.
    Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory Board
  • Mr. Salim Gulamabbas Hamir F.C.A.
    Company Secretary














TRLS Stock Analysis - Frequently Asked Questions

How have TRLS shares performed in 2024?

Trellus Health's stock was trading at GBX 3.25 at the beginning of the year. Since then, TRLS stock has increased by 15.4% and is now trading at GBX 3.75.
View the best growth stocks for 2024 here
.

How do I buy shares of Trellus Health?

Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:TRLS) was last updated on 2/23/2024 by MarketBeat.com Staff